Effects of a novel anticoagulant compound (TV7130) in an ovine model of septic shock.
We compared the effects of a new compound (TV7130) with those of activated protein C (APC) in a large animal model of septic shock. Thirty-two fasted, anesthetized, invasively monitored, mechanically ventilated female sheep received 1.5 g/kg body weight of feces into the abdomen to induce sepsis. Immediately after feces injection, all animals received a bolus followed by a continuous infusion of saline (n = 8, bolus 1.5 mL for 15 min, infusion 1.5 mL/[kg·h]), low-dose TV7130 (n = 8; 0.4 mg/kg bolus, 0.4 mg/[kg·h] infusion), high-dose TV7130 (n = 8; 0.8 mg/kg bolus, 0.8 mg/[kg·h] infusion), or APC (n = 8; saline bolus, APC infusion of 0.024 mg/[kg·h]). Experiments were pursued until each sheep's spontaneous death. There were no significant differences among groups in heart rate or cardiac index, but mean arterial pressure, systemic vascular resistance index, and left ventricular stroke work index decreased less in the high-dose TV7130 and APC groups than in the other groups. Gas exchange was preserved better in the high-dose TV7130 and APC groups. Interleukin 6 and lactate concentrations were lower in the high-dose TV7130 and APC groups than in the other groups. Functional capillary density and proportion of perfused vessels, evaluated in the sublingual region using sidestream dark-field videomicroscopy, were significantly higher in the TV7130 and APC groups than in the vehicle group at 16 h. Survival time was significantly longer in the high-dose TV7130 and APC groups than in the other groups (log-rank test, P = 0.0002). TV7130 has similar effects to APC and may be a promising agent for the management of severe sepsis.
Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Fuhong
F
Su
Hongchuan
H
Huang
Xinrong
X
He
Davide
D
Simion
David
D
Simuen
Jingwei
J
Xie
Aric
A
Orbach
Orit
O
Cohen-Barak
Michael
M
Piagnerelli
Jean-Louis
JL
Vincent
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D008833:Microcirculation; D011486:Protein C / Q000378:metabolism; D012756:Sheep; D012772:Shock, Septic / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism
D000925:Anticoagulants; D011486:Protein C